Stiris Ranks 23rd on Profit/Chatelaine W100
PROFIT and Chatelaine today ranked Stiris Research Inc. No. 23 on the 17th annual W100 list of Canada’s Top Female Entrepreneurs. Published in the June issue of Canadian Business (available now) and online at PROFITguide.com and Chatelaine.com, the W100 ranks female entrepreneurs with a proprietary formula that considers the size, growth rate and profitability of the businesses they own and run.
“You need a bold vision, an innovative strategy and loads of tenacity to earn a spot on the W100,” says James Cowan, Editor-in-chief of PROFIT and Canadian Business. “Every person on this list represents the pinnacle of business success in Canada. Their stories are inspiring and instructive for those seeking to excel as an entrepreneur.”
“Stiris Research is honoured to be on the PROFIT W100 ranking,” said President & CEO Shantal Feltham. “When you accomplish things, you have to recognize how you got there and who helped you along the way. Celebrations aren’t just about celebrating the outcome, they’re also about celebrating the people and process that lead to that outcome. Today, I’m celebrating my team and the company they’ve helped develop.”
ABOUT THE PROFIT/CHATELAINE W100
Now in its 17th year, the PROFIT/Chatelaine W100 ranking of Canada’s Top Female Entrepreneurs is Canada’s largest celebration of achievement by women business owners. Produced by the editors of PROFIT and Chatelaine, the rankings and extended coverage of the women honoured are published in print and online. Applicants to the 2015 W100 were ranked using a proprietary formula that considers the size, growth rate and profitability of the companies they own and manage. To see this year’s complete ranking and find links to all of our W100 editorial coverage, visit http://www.profitguide.com/w100.
About Stiris Research
Stiris Research is an entrepreneurial Clinical Trial Management company specializing in conducting complex Phase I through IIIB trials for North American biotechnology and biopharmaceutical companies, with a focus on Oncology, CNS and Neurology. Stiris Research was formed as a result of listening to the stakeholders engaged in clinical trials, identifying their unmet needs, and developing a unique, value-based approach to address those needs.
For more information, please contact: